Brunetti, A.; Antonini, S.; Saladino, A.; Lavezzi, E.; Zampetti, B.; Cozzi, R.
Clinical Management of Acromegaly: Therapeutic Frontiers and New Perspectives for Somatostatin Receptor Ligands (SRLs). Medicina 2022, 58, 794.
https://doi.org/10.3390/medicina58060794
AMA Style
Brunetti A, Antonini S, Saladino A, Lavezzi E, Zampetti B, Cozzi R.
Clinical Management of Acromegaly: Therapeutic Frontiers and New Perspectives for Somatostatin Receptor Ligands (SRLs). Medicina. 2022; 58(6):794.
https://doi.org/10.3390/medicina58060794
Chicago/Turabian Style
Brunetti, Alessandro, Simone Antonini, Andrea Saladino, Elisabetta Lavezzi, Benedetta Zampetti, and Renato Cozzi.
2022. "Clinical Management of Acromegaly: Therapeutic Frontiers and New Perspectives for Somatostatin Receptor Ligands (SRLs)" Medicina 58, no. 6: 794.
https://doi.org/10.3390/medicina58060794
APA Style
Brunetti, A., Antonini, S., Saladino, A., Lavezzi, E., Zampetti, B., & Cozzi, R.
(2022). Clinical Management of Acromegaly: Therapeutic Frontiers and New Perspectives for Somatostatin Receptor Ligands (SRLs). Medicina, 58(6), 794.
https://doi.org/10.3390/medicina58060794